Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis
dc.contributor.author | Jinagal, J | en_US |
dc.contributor.author | Gupta, G | en_US |
dc.contributor.author | Agarwal, A | en_US |
dc.contributor.author | Aggarwal, K | en_US |
dc.contributor.author | Akella, M | en_US |
dc.contributor.author | Gupta, V | en_US |
dc.contributor.author | Suri, D | en_US |
dc.contributor.author | Gupta, A | en_US |
dc.contributor.author | Singh, S | en_US |
dc.contributor.author | Ram, J | en_US |
dc.date.accessioned | 2020-04-10T02:01:45Z | |
dc.date.available | 2020-04-10T02:01:45Z | |
dc.date.issued | 2019-01 | |
dc.description.abstract | Purpose: To assess the safety and efficacy of intraoperative intravitreal dexamethasone implant in patients of juvenile idiopathic arthritis (JIA)-associated uveitis undergoing phacoemulsification with posterior chamber intraocular lens (PCIOL) implantation. Methods: Retrospectively, data of patients with JIA-associated uveitis undergoing phacoemulsification with PCIOL implantation with intraoperative dexamethasone implant injection were analyzed. Patients with a minimum follow-up of 6 months were included. Primary outcome measures were ocular inflammation, intraocular pressure (IOP), best-corrected visual acuity (BCVA), and worsening of uveitis. Results: 8 eyes of 6 patients were included. BCVA was significantly improved at 1, 3, and 6 months postoperatively 0.20 ± 0.09, P = 0.008; 0.18 ± 0.11, P = 0.008; and 0.24 ± 0.11, P = 0.01, respectively. No statistical difference noted in mean IOP at various follow-up visits. None developed worsening of uveitis or Cystoid macular edema. Conclusion: Intraoperative intravitreal dexamethasone implant is a safe and effective in preventing and managing the postoperative inflammation in children with JIA-associated uveitic cataract. | en_US |
dc.identifier.affiliations | Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India | en_US |
dc.identifier.affiliations | Department of Pediatrics, Division of Allergy and Immunology, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India | en_US |
dc.identifier.citation | Jinagal J, Gupta G, Agarwal A, Aggarwal K, Akella M, Gupta V, Suri D, Gupta A, Singh S, Ram J. Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis. Indian Journal of Ophthalmology. 2019 Jan; 67(1): 69-74 | en_US |
dc.identifier.issn | 0301-4738 | |
dc.identifier.issn | 1998-3689 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/197054 | |
dc.language | en | en_US |
dc.publisher | All India Ophthalmological Society | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 67 | en_US |
dc.source.uri | https://dx.doi.org/10.4103/ijo.IJO_713_18 | en_US |
dc.subject | Children | en_US |
dc.subject | cataract surgery | en_US |
dc.subject | dexamethasone implant | en_US |
dc.subject | JIA | en_US |
dc.subject | juvenile idiopathic arthritis | en_US |
dc.subject | phacoemulsification | en_US |
dc.subject | uveitis | en_US |
dc.title | Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1